WO2001075039A3 - Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide - Google Patents
Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide Download PDFInfo
- Publication number
- WO2001075039A3 WO2001075039A3 PCT/CN2001/000423 CN0100423W WO0175039A3 WO 2001075039 A3 WO2001075039 A3 WO 2001075039A3 CN 0100423 W CN0100423 W CN 0100423W WO 0175039 A3 WO0175039 A3 WO 0175039A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- rna helicase
- human rna
- discloses
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 108060004795 Methyltransferase Proteins 0.000 title 1
- 108090000944 RNA Helicases Proteins 0.000 abstract 2
- 102000004409 RNA Helicases Human genes 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne un nouveau polypeptide, une ARN hélicase humaine 10, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour l'ARN hélicase humaine 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU58158/01A AU5815801A (en) | 2000-03-27 | 2001-03-26 | A novel polypeptide, human rna helicase 10 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00115155 CN1315542A (zh) | 2000-03-27 | 2000-03-27 | 一种新的多肽——人rna解旋酶10和编码这种多肽的多核苷酸 |
| CN00115155.X | 2000-03-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001075039A2 WO2001075039A2 (fr) | 2001-10-11 |
| WO2001075039A3 true WO2001075039A3 (fr) | 2002-02-07 |
Family
ID=4584624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000423 WO2001075039A2 (fr) | 2000-03-27 | 2001-03-26 | Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1315542A (fr) |
| AU (1) | AU5815801A (fr) |
| WO (1) | WO2001075039A2 (fr) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888792A (en) * | 1997-07-11 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | ATP-dependent RNA helicase protein |
-
2000
- 2000-03-27 CN CN 00115155 patent/CN1315542A/zh active Pending
-
2001
- 2001-03-26 AU AU58158/01A patent/AU5815801A/en not_active Abandoned
- 2001-03-26 WO PCT/CN2001/000423 patent/WO2001075039A2/fr active Application Filing
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888792A (en) * | 1997-07-11 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | ATP-dependent RNA helicase protein |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE GENBANK [online] 23 November 1999 (1999-11-23), WRAY P. ET AL., retrieved from GI:4826431 accession no. NCBI Database accession no. AL031447 * |
| DATABASE GENBANK [online] 9 November 1995 (1995-11-09), GONZALEZ G.C. ET AL., retrieved from GI:1055214 accession no. NCBI Database accession no. AAC43487 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5815801A (en) | 2001-10-15 |
| WO2001075039A2 (fr) | 2001-10-11 |
| CN1315542A (zh) | 2001-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001075039A3 (fr) | Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075036A3 (fr) | Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001075016A3 (fr) | Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2002000821A3 (fr) | Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide | |
| WO2001075011A3 (fr) | Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide | |
| WO2001075048A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide | |
| WO2001083687A3 (fr) | Nouveau polypeptide, proteine pax humaine 23, et polynucleotide codant pour ce polypeptide | |
| WO2001077287A3 (fr) | Nouveau polypeptide, globine humaine de l'uterus 11, et polynucleotide codant pour ce polypeptide | |
| WO2001075024A3 (fr) | Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide | |
| WO2001075061A3 (fr) | Nouveau polypeptide, cdv-1-42, et polynucleotide codant pour ce polypeptide | |
| WO2001083682A3 (fr) | Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide | |
| WO2001075056A3 (fr) | Nouveau polypeptide, clathrine humaine a chaine legere 20, et polynucleotide codant pour ce polypeptide | |
| WO2001075028A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s4-12, et polynucleotide codant pour ce polypeptide | |
| WO2001075057A3 (fr) | Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide | |
| WO2001075053A3 (fr) | Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001077286A3 (fr) | Nouveau polypeptide, globine humaine 58 de l'uterus, et un polynucleotide codant pour ce polypeptide | |
| WO2001083681A3 (fr) | Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide | |
| WO2002000828A3 (fr) | Nouveau polypeptide, proteine a doigt de zinc 34, et polynucleotide codant ce polypeptide | |
| WO2001075058A3 (fr) | Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide | |
| WO2001075007A3 (fr) | Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide | |
| WO2001079431A3 (fr) | Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide | |
| WO2001075035A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001075034A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide | |
| WO2001075002A3 (fr) | Nouveau polypeptide, gène de regulation du cycle cellulaire humain 28, et polynucléotide codant pour ce polypeptide | |
| WO2001081538A3 (fr) | Nouveau polypeptide, connexine humaine 9, et polynucleotide codant pour ce polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |